|4Sep 9, 7:13 PM ET

DST Capital LLC 4

4 · Biostage, Inc. · Filed Sep 9, 2021

Insider Transaction Report

Form 4
Period: 2021-09-01
Transactions
  • Purchase

    Warrant (right to buy)

    2021-09-01+250,000250,000 total
    Exercise: $2.00From: 2021-09-01Exp: 2026-09-01Common Stock (250,000 underlying)
  • Purchase

    Common Stock

    2021-09-01$2.00/sh+500,000$1,000,0003,650,000 total
Holdings
  • Common Stock

    (indirect: Owned by sole member of reporting person)
    30,722
Footnotes (1)
  • [F1]On September 1, 2021, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 500,000 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 250,000 shares of common stock with an exercise price of $2.00 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $1,000,000.

Documents

1 file
  • 4
    tm2127249-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT